Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 329, 372-384
Abstract
No abstract availableKeywords
Funding Information
- National University of Singapore (R-148-000-282-133, R-148-000-297-114)
- Astellas Pharma
This publication has 59 references indexed in Scilit:
- Impact of Molecular Weight on Lymphatic Drainage of a Biopolymer-Based Imaging AgentPharmaceutics, 2012
- Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticlesInternational Journal of Pharmaceutics, 2012
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug deliveryJournal of Pharmaceutical Sciences, 2010
- Basic immunosuppressive drugs outside solid organ transplantationExpert Opinion on Investigational Drugs, 2006
- TacrolimusDrugs, 2003
- Importance of the test medium for the release kinetics of a somatostatin analogue from poly(?-lactide-co-glycolide) microspheresInternational Journal of Pharmaceutics, 1999
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- Interstitial Fluid Concentrations of Albumin and Immunoglobulin G in Normal MenScandinavian Journal of Clinical and Laboratory Investigation, 1974
- Subcutaneous Interstitial Fluid Albumin Concentration in Long-Term Diabetes MellitusScandinavian Journal of Clinical and Laboratory Investigation, 1973